Metropolitan Life Insurance CO Meridian Bioscience Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

39 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 14, 2023	BUY	$31.15 - $33.39 $82,827 - $88,784	2,659 New	2,659 $88.3 Million
Q4 2022 Mar 30, 2023	BUY	$31.15 - $33.39 $4,329 - $4,641	139 Added 5.52%	2,659 $88,000
Q4 2022 Feb 15, 2023	BUY	$31.15 - $33.39 $4,329 - $4,641	139 Added 5.52%	2,659 $88,000
Q3 2022 Jun 14, 2023	BUY	$30.9 - $33.55 $77,868 - $84,546	2,520 New	2,520 $79.5 Million
Q2 2022 Jun 20, 2023	BUY	$23.75 - $31.69 $59,850 - $79,858	2,520 New	2,520 $76,000
Q1 2022 Jun 20, 2023	BUY	$19.97 - $26.94 $50,324 - $67,888	2,520 New	2,520 $65,000
Q1 2022 Mar 30, 2023	SELL	$19.97 - $26.94 $180,568 - $243,591	-9,042 Reduced 78.2%	2,520 $65,000
Q1 2022 May 12, 2022	SELL	$19.97 - $26.94 $180,568 - $243,591	-9,042 Reduced 78.2%	2,520 $65,000
Q4 2021 Jun 21, 2023	BUY	$17.46 - $21.61 $201,872 - $249,854	11,562 New	11,562 $235,000
Q4 2021 Mar 30, 2023	SELL	$17.46 - $21.61 $41,956 - $51,928	-2,403 Reduced 17.21%	11,562 $235,000
Q4 2021 Feb 15, 2022	SELL	$17.46 - $21.61 $41,956 - $51,928	-2,403 Reduced 17.21%	11,562 $236,000
Q3 2021 Jun 21, 2023	BUY	$17.35 - $22.5 $242,292 - $314,212	13,965 New	13,965 $268,000
Q2 2021 Jun 21, 2023	BUY	$18.01 - $28.32 $251,509 - $395,488	13,965 New	13,965 $309,000
Q2 2021 Mar 30, 2023	BUY	$18.01 - $28.32 $13,201 - $20,758	733 Added 5.54%	13,965 $309,000
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $251,275 - $395,120	13,952 Added 107323.08%	13,965 $310,000
Q1 2021 Jun 26, 2023	BUY	$19.76 - $29.89 $261,464 - $395,504	13,232 New	13,232 $347 Million
Q1 2021 Mar 30, 2023	SELL	$19.76 - $29.89 $14,148 - $21,401	-716 Reduced 5.13%	13,232 $347,000
Q1 2021 May 14, 2021	SELL	$19.76 - $29.89 $275,355 - $416,517	-13,935 Reduced 99.91%	13 $347,000
Q4 2020 Jun 22, 2023	BUY	$15.73 - $21.66 $219,402 - $302,113	13,948 New	13,948 $260,000
Q3 2020 Jun 26, 2023	BUY	$13.54 - $26.41 $188,855 - $368,366	13,948 New	13,948 $236,000
Q2 2020 Jun 26, 2023	BUY	$7.84 - $23.29 $109,352 - $324,848	13,948 New	13,948 $324,000
Q1 2020 Jul 12, 2023	BUY	$5.57 - $11.5 $77,690 - $160,402	13,948 New	13,948 $117,000
Q1 2020 Mar 30, 2023	BUY	$5.57 - $11.5 $1,370 - $2,829	246 Added 1.8%	13,948 $117,000
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $1,370 - $2,829	246 Added 1.8%	13,948 $117,000
Q4 2019 Jul 12, 2023	BUY	$7.9 - $10.14 $108,245 - $138,938	13,702 New	13,702 $133,000
Q4 2019 Mar 30, 2023	SELL	$7.9 - $10.14 $11,225 - $14,408	-1,421 Reduced 9.4%	13,702 $133,000
Q4 2019 Feb 14, 2020	SELL	$7.9 - $10.14 $11,225 - $14,408	-1,421 Reduced 9.4%	13,702 $134,000
Q3 2019 Jul 12, 2023	BUY	$9.17 - $12.01 $138,677 - $181,627	15,123 New	15,123 $143,000
Q2 2019 Jul 12, 2023	BUY	$10.88 - $17.6 $164,538 - $266,164	15,123 New	15,123 $179,000
Q1 2019 Jul 13, 2023	BUY	$15.51 - $17.61 $234,557 - $266,316	15,123 New	15,123 $266,000
Q1 2019 Mar 30, 2023	BUY	$15.51 - $17.61 $193,316 - $219,491	12,464 Added 468.75%	15,123 $266,000
Q1 2019 May 16, 2019	BUY	$15.51 - $17.61 $166,251 - $188,761	10,719 Added 243.39%	15,123 $266,000
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $166,251 - $188,761	-10,719 Reduced 70.88%	4,404 $607,000
Q4 2018 Jul 13, 2023	BUY	$14.52 - $19.72 $219,585 - $298,225	15,123 New	15,123 $262,000
Q4 2018 Feb 14, 2019	BUY	$14.52 - $19.72 $178,625 - $242,595	12,302 Added 436.09%	15,123 $263,000
Q3 2018 Jul 13, 2023	BUY	$14.85 - $16.35 $212,369 - $233,821	14,301 New	14,301 $213 Million
Q3 2018 Nov 14, 2018	SELL	$14.85 - $16.35 $170,478 - $187,698	-11,480 Reduced 80.27%	2,821 $42,000
Q4 2017 Feb 15, 2018	SELL	$13.55 - $15.8 $236,366 - $275,615	-17,444 Reduced 54.95%	14,301 $200,000
Q2 2017 Aug 14, 2017	BUY	N/A	31,745	31,745 $500,000

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account